Vor Biopharma Inc. - Common Stock, $0.0001 par value per share (VOR)

CUSIP: 929033207

Q3 2026 13F Holders as of 30 Sep 2026

Holder snapshot 6 signals
Share change
-14,923
SEC-reported price per share
$19.08
Number of holders
20
Value change
-$275,591
Number of buys
16
Number of sells
3
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
53,761,929

Security key

929033207

Report period

Q3 2026

Institutions

20

Top holders

10

Ownership snapshot

Top reported holders of VOR - Vor Biopharma Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
RA CAPITAL MANAGEMENT, L.P.
Disclosed value leader
RA CAPITAL MANAGEMENT, L.P.
Comparable rows
13/15
Latest evidence
31 Jul 2026
13D/G 13F 3/4/5 Lead comparable stake: 20% 2 rows are not safely comparable across share classes. 13D/G row: RA CAPITAL MANAGEMENT, L.P. Showing 1-6 of 15 holder rows.

Quick read

RA CAPITAL MANAGEMENT, L.P. leads the comparable SEC ownership view at 20%.

13 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens RA CAPITAL MANAGEMENT, L.P.'s linked filing trail.
Comparable ownership Top 5
RA CAPITAL MANAGEMENT, L.P. 20%
Reprogrammed Interchange LLC 18%
FMR LLC 12%
TCG Crossover GP II, LLC 10%
ForGrowth III PA B.V. 10%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
RA CAPITAL MANAGEMENT, L.P.
13D/G 13F
Company
20%
Reported 13D/G · 16 Jul 2026
$238,185,911
12,937,855 shares
+$138,559,809 16 Jul 2026
Reprogrammed Interchange LLC
13D/G 3/4/5
10%+ Owner
18%
Reported 13D/G · 15 Oct 2025
$48,045,191
1,204,442 shares
$0 15 Oct 2025
FMR LLC
13D/G 13F
Company
12%
Reported 13D/G · 31 Jul 2026
$128,572,421
6,509,996 shares
+$31,162,478 31 Jul 2026
TCG Crossover GP II, LLC
3/4/5 13D/G
10%+ Owner · Chen Yu
10%
Reported 13D/G · 30 Mar 2026
$37,101,930
2,836,539 shares
— 30 Mar 2026
ForGrowth III PA B.V.
13D/G
10%
Reported 13D/G · 18 Dec 2025
$81,492,203
10,237,714 shares
+$25,772,203 18 Dec 2025
Venrock Healthcare Capital Partners III, L.P.
13D/G
9.9%
Reported 13D/G · 30 Jun 2026
$112,108,308
5,676,370 shares
+$11,701,737 30 Jun 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
20
Shares
95,259
Rows available
20
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2026 vs Q2 2026 Across Filers

Q2 2026 holders
102
Q3 2026 holders
20
Holder diff
-82
Investor Q2 2026 Shares Q3 2026 Shares Share Diff Share Chg % Q2 2026 value Q3 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .